Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Lifecare AS ( (DE:LFC0) ) is now available.
Lifecare ASA is a medical sensor company focused on developing osmotic pressure-based technology for next-generation continuous glucose monitoring systems and broader analyte tracking in humans and pets. The company aims to leverage its sensor platform to address growing demand for advanced diagnostic and monitoring solutions.
Lifecare has reminded investors that the exercise window for Warrants Series 1, issued in connection with its January 2026 rights issue, expires today at 16:30 CET, after which unexercised warrants will lapse worthless and may dilute non-participating holders. The company also disclosed that insider-related Hannibal Invest AS exercised 90,000 Series 1 warrants at NOK 0.3342 per share, and Lifecare expects the resulting share capital increase to be registered around 25 March 2026 with new shares delivered to subscribers around 26 March 2026, marking a further step in strengthening its capital base.
More about Lifecare AS
Lifecare ASA is a medical sensor company focused on developing technology for sensing and monitoring various body analytes in humans and pets. Its primary strategic focus is next-generation continuous glucose monitoring systems based on osmotic pressure sensing, a platform that can be adapted to detect a wide range of molecules.
Average Trading Volume: 3,951,568
Current Market Cap: NOK114.6M
Find detailed analytics on LFC0 stock on TipRanks’ Stock Analysis page.